Vor Biopharma Stock Probability of Future Stock Price Finishing Over 18.70
| VOR Stock | USD 0.85 0.01 1.72% |
Vor |
Vor Biopharma Target Price Odds to finish over 18.70
The tendency of Vor Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 18.70 or more in 90 days |
| 0.86 | 90 days | 18.70 | close to zero percent |
Based on a normal probability distribution, the odds of Vor Biopharma to move over $ 18.70 or more in 90 days from now is close to zero percent (This Vor Biopharma probability density function shows the probability of Vor Stock to fall within a particular range of prices over 90 days) . Probability of Vor Biopharma price to stay between its current price of $ 0.86 and $ 18.70 at the end of the 90-day period is about 32.47 .
Considering the 90-day investment horizon the stock has the beta coefficient of 1.81 . This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Vor Biopharma will likely underperform. Additionally Vor Biopharma has an alpha of 0.0439, implying that it can generate a 0.0439 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Vor Biopharma Price Density |
| Price |
Predictive Modules for Vor Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vor Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Vor Biopharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Vor Biopharma is not an exception. The market had few large corrections towards the Vor Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Vor Biopharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Vor Biopharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.04 | |
β | Beta against Dow Jones | 1.81 | |
σ | Overall volatility | 0.11 | |
Ir | Information ratio | 0.01 |
Vor Biopharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vor Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vor Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Vor Biopharma had very high historical volatility over the last 90 days | |
| Vor Biopharma has some characteristics of a very speculative penny stock | |
| Vor Biopharma has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (117.86 M) with profit before taxes, overhead, and interest of 0. | |
| Vor Biopharma has about 151.09 M in cash with (100.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.97, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Vor Biopharma has a frail financial position based on the latest SEC disclosures | |
| Over 81.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from news.google.com: Vor Biopharma Inc. Receives 11.36 Consensus Price Target from Brokerages - MarketBeat |
Vor Biopharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vor Stock often depends not only on the future outlook of the current and potential Vor Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vor Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 67.2 M | |
| Cash And Short Term Investments | 137.2 M |
Vor Biopharma Technical Analysis
Vor Biopharma's future price can be derived by breaking down and analyzing its technical indicators over time. Vor Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Vor Biopharma. In general, you should focus on analyzing Vor Stock price patterns and their correlations with different microeconomic environments and drivers.
Vor Biopharma Predictive Forecast Models
Vor Biopharma's time-series forecasting models is one of many Vor Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Vor Biopharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Vor Biopharma
Checking the ongoing alerts about Vor Biopharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Vor Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Vor Biopharma had very high historical volatility over the last 90 days | |
| Vor Biopharma has some characteristics of a very speculative penny stock | |
| Vor Biopharma has high likelihood to experience some financial distress in the next 2 years | |
| Reported Net Loss for the year was (117.86 M) with profit before taxes, overhead, and interest of 0. | |
| Vor Biopharma has about 151.09 M in cash with (100.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.97, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Vor Biopharma has a frail financial position based on the latest SEC disclosures | |
| Over 81.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from news.google.com: Vor Biopharma Inc. Receives 11.36 Consensus Price Target from Brokerages - MarketBeat |
Additional Tools for Vor Stock Analysis
When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.